Only one progestin implant is available in the US; it is a 4-cm, match-sized single-rod implant that can be inserted through a trocar subdermally at the groove between the bicep and tricep. No skin incision is required. The implant releases etonogestrel (a progestin) at an average rate of 50 mcg/day at 12 mo. The implant provides effective contraception for up to 3 yr. Before inserting or removing this implant, health care practitioners must complete 3 h of manufacturer-sponsored training. The implant currently available is bioequivalent to the previously used implant but is designed to be radiopaque to make it easier to locate at the time of removal. Also, the insertion applicator is easier to use, so that the implant is less likely to be inserted too deeply.
A subdermal implant may be inserted at any time during the menstrual cycle. However, if unprotected intercourse has occurred within the past month, another contraceptive method should be used concurrently until pregnancy can be reliably excluded by a negative pregnancy test or by the subsequent occurrence of menses. If the implant is inserted during the first 5 days of menstrual cycle, no backup contraceptive method is needed. If it is not inserted during this time frame, a backup contraceptive method should be used concurrently for at least 3 days. The implant may be inserted immediately after spontaneous or induced abortion or immediately postpartum regardless of breastfeeding status.
The most common adverse effects are similar to those of other progestins (irregular vaginal bleeding, amenorrhea, headache). Removing the implant, which should be done no later than 3 yr after insertion, requires a skin incision. After implant removal, ovarian activity normalizes immediately.
Other contraceptive implants are available elsewhere in the world.
Last full review/revision June 2013 by Laura Sech; Penina Segall-Gutierrez, MD, MSc; Emily Silverstein; Daniel R. Mishell, Jr., MD
Content last modified August 2013